As a Zostavax vaccine injury lawyer TN trusts, I am offering a free legal consultation to anyone injured by the Zostavax shingles vaccine.

Hundreds of people are suing Merck, the company that manufactures the popular shingles vaccine Zostavax. While Merck developed Zostavax to prevent shingles in adults 50 years and older, claimants allege that Zostavax caused their shingles. This is why I am a Zostavax vaccine injury lawyer TN residents rely on: to stand up to Big Pharma and hold them accountable for their actions. 

Read on for everything you need to know about Merck and how they allegedly improperly formulated the vaccine. 

The facts you need to know

The Zostavax shingles vaccine is given in one shot, in a single dose. It also contains a dose of the live shingles virus (herpes zoster) and has been in use since 2006. While the vaccine has been widely marketed as safe, reports link thousands of hospitalizations and disabilities to the vaccine. These alleged injuries include shingles, chickenpox, facial paralysis, vision loss, heart failure, and even death. What’s worse, Merck has made billions of dollars in profit from its Zostavax vaccine. 

If you received a Zostavax vaccination and then developed shingles, Bell’s palsy, heart failure, or if your loved one passed away within six months of receiving the Zostavax shot, contact us right away. You may be eligible for financial compensation for your Zostavax injury.

Contact Darrell Castle & Associates, PLLC today for a completely free consultation.

The National Childhood Vaccine Injury Act of 1986 does not cover the Zostavax shingles vaccine. This means that you can sue the vaccine manufacturer directly for your injuries associated with its use. It also means you’ll need an experienced lawyer who knows how to take on Big Pharma’s lawyers, and win. And I am proud to say that I have I have a winning track record doing just that.

Don’t wait. Call us at (901) 327-1212 or reach us online to speak with a Zostavax injury lawyer TN trusts, with absolutely no strings attached. We look forward to hearing from you.